Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Protocol of Preoperative Combined Radiation and Chemotherapy for Resectable Primary Rectal Cancer

NCT00232453 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00232453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Protocol of Preoperative Combined Radiation and Chemotherapy for Resectable Primary Rectal Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2001
Completion date
December 31, 2004
Enrollment
34
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms